Illumina

In early 2014, Illumina unveiled a series of products to complement its existing next-generation sequencing portfolio. These products, which include the TruSight Myeloid Sequencing Panel, are designed to help support and streamline workflows for cancer research

As healthcare markets become more demanding, and advancing organisations in different sectors look for different solutions to stay at the forefront of medical services, genome research and analytics have become vital. It’s here that firms such as Illumina become pivotal. The company – based in California – leads the way in the biotechnological sphere and provides key tools and capacities for firms to determine better medical results. Much lauded for its research and development facilities, Illumina goes from strength to strength.